NEAUVIA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Neauvia Intense Rose
Neauvia Intense Rose is a sterile, non-pyrogenic, injectable monophasic filler, indicated for the correction of vulvar atrophy and the symptoms related to it by intradermal injection. It consists of highly purified sodium hyaluronate of non-animal origin derived from bacterial fermentation, cross-linked with PEG at 28 mg/mL, with glycine and L-proline in buffered non-pyrogenic water. The hydrogel is gelatinous, transparent and colourless, supplied in a pre-filled 1,0 ml disposable syringe with a luer-lock connection. It contains no anaesthetic, and the product degrades slowly after implanting.
Key Benefits of Neauvia Intense Rose
- Indicated for the correction of vulvar atrophy and the symptoms related to it
- 28 mg/mL cross-linked sodium hyaluronate of non-animal origin from bacterial fermentation
- Enriched with glycine and L-proline in buffered non-pyrogenic water
- Contains no anaesthetic, which reduces the scope for allergic reaction
- Supplied in a pre-filled 1,0 ml disposable syringe with a luer-lock connection
- Suitable for use with a needle from 21G up to 25G
- Degrades slowly after implanting
Indications and Professional Use
Main indications
- Correction of vulvar atrophy
- Correction of the symptoms related to vulvar atrophy
Professional use
For professional use. Use of Neauvia Intense Rose is reserved exclusively for trained practitioners with a good anatomical knowledge of the site to be treated, and it is not for retail sale or self-administration. It must be implanted in proper conditions in a suitable environment, with the current rules of asepsis rigorously observed and the skin disinfected with iodopovidone or chlorhexidine. It must not be injected into blood vessels, into the clitoral area or labia minora, into areas too close to or within the urethra, or into the mammary gland or internal genitals, and it must not be injected close to menstruation, used simultaneously with laser treatment, deep chemical peels or dermabrasion, or overcorrected.
Treatment areas
- Labia majora
Patient profile
For adult patients presenting with vulvar atrophy, assessed by a practitioner with good anatomical knowledge of the site to be treated. It must not be used in patients with auto-immune disorders affecting the skin; infections or inflammations such as genital herpes or dermatitis at or near the treatment zone; varices in the area of the implant; patients receiving anticoagulant treatment; patients undergoing radiation or ultrasound therapy in the area of the implant; known hypersensitivity to hyaluronic acid; a tendency to develop hypertrophic scarring; untreated epilepsy; or severe allergies. It must not be injected in pregnant or breastfeeding women, in anyone under 18 years of age, or in patients already treated with temporary or permanent fillers in the same area.
How Neauvia Intense Rose Works
Intense Rose is injected intradermally into the labia majora, where the cross-linked hydrogel restores volume lost to vulvar atrophy. The manufacturer's recommended technique is slow, retrograde sliding injection, with the product shaped by the operator's free hand during placement and the treated area massaged gently afterwards to distribute it. Because the device contains no anaesthetic, the practitioner assesses separately whether local anaesthesia is appropriate; where it is, a troncular nerve block is advised. The gel degrades slowly after implanting rather than resolving to a fixed endpoint.
Why Order From Allpara
Allpara offers genuine, verified NEAUVIA products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
How does Intense Rose differ from the rest of the Neauvia range?
Indication and regulatory route. Intense Rose is the only reference indicated for vulvar atrophy, placed intradermally in the labia majora, and it is regulated as a Class III device under the Medical Device Directive 93/42/EEC with notified body 0373. The face and lip references are regulated under Regulation (EU) 2017/745.
What should the patient avoid after treatment with Intense Rose?
Sexual activity for five days, activities that put pressure on the treated area such as cycling or horseback riding for several days, wet locations including swimming pools, gyms and steam rooms for ten days, intense UVA-B and sun exposure for two weeks, surgery or dental work for two weeks, and beauty treatments such as laser or peeling in the treated area for three weeks.
Where can clinics buy Neauvia Intense Rose?
ALLPARA supplies Neauvia Intense Rose to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.
More from Matex Lab S.P.A
Clinic alternatives
Pick up where you left off
Neauvia Intense Rose
Neauvia Intense Rose is a sterile, non-pyrogenic, injectable monophasic filler, indicated for the correction of vulvar atrophy and the symptoms related to it by intradermal injection. It consists of highly purified sodium hyaluronate of non-animal origin derived from bacterial fermentation, cross-linked with PEG at 28 mg/mL, with glycine and L-proline in buffered non-pyrogenic water. The hydrogel is gelatinous, transparent and colourless, supplied in a pre-filled 1,0 ml disposable syringe with a luer-lock connection. It contains no anaesthetic, and the product degrades slowly after implanting.
Key Benefits of Neauvia Intense Rose
- Indicated for the correction of vulvar atrophy and the symptoms related to it
- 28 mg/mL cross-linked sodium hyaluronate of non-animal origin from bacterial fermentation
- Enriched with glycine and L-proline in buffered non-pyrogenic water
- Contains no anaesthetic, which reduces the scope for allergic reaction
- Supplied in a pre-filled 1,0 ml disposable syringe with a luer-lock connection
- Suitable for use with a needle from 21G up to 25G
- Degrades slowly after implanting
Indications and Professional Use
Main indications
- Correction of vulvar atrophy
- Correction of the symptoms related to vulvar atrophy
Professional use
For professional use. Use of Neauvia Intense Rose is reserved exclusively for trained practitioners with a good anatomical knowledge of the site to be treated, and it is not for retail sale or self-administration. It must be implanted in proper conditions in a suitable environment, with the current rules of asepsis rigorously observed and the skin disinfected with iodopovidone or chlorhexidine. It must not be injected into blood vessels, into the clitoral area or labia minora, into areas too close to or within the urethra, or into the mammary gland or internal genitals, and it must not be injected close to menstruation, used simultaneously with laser treatment, deep chemical peels or dermabrasion, or overcorrected.
Treatment areas
- Labia majora
Patient profile
For adult patients presenting with vulvar atrophy, assessed by a practitioner with good anatomical knowledge of the site to be treated. It must not be used in patients with auto-immune disorders affecting the skin; infections or inflammations such as genital herpes or dermatitis at or near the treatment zone; varices in the area of the implant; patients receiving anticoagulant treatment; patients undergoing radiation or ultrasound therapy in the area of the implant; known hypersensitivity to hyaluronic acid; a tendency to develop hypertrophic scarring; untreated epilepsy; or severe allergies. It must not be injected in pregnant or breastfeeding women, in anyone under 18 years of age, or in patients already treated with temporary or permanent fillers in the same area.
How Neauvia Intense Rose Works
Intense Rose is injected intradermally into the labia majora, where the cross-linked hydrogel restores volume lost to vulvar atrophy. The manufacturer's recommended technique is slow, retrograde sliding injection, with the product shaped by the operator's free hand during placement and the treated area massaged gently afterwards to distribute it. Because the device contains no anaesthetic, the practitioner assesses separately whether local anaesthesia is appropriate; where it is, a troncular nerve block is advised. The gel degrades slowly after implanting rather than resolving to a fixed endpoint.
Why Order From Allpara
Allpara offers genuine, verified NEAUVIA products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
How does Intense Rose differ from the rest of the Neauvia range?
Indication and regulatory route. Intense Rose is the only reference indicated for vulvar atrophy, placed intradermally in the labia majora, and it is regulated as a Class III device under the Medical Device Directive 93/42/EEC with notified body 0373. The face and lip references are regulated under Regulation (EU) 2017/745.
What should the patient avoid after treatment with Intense Rose?
Sexual activity for five days, activities that put pressure on the treated area such as cycling or horseback riding for several days, wet locations including swimming pools, gyms and steam rooms for ten days, intense UVA-B and sun exposure for two weeks, surgery or dental work for two weeks, and beauty treatments such as laser or peeling in the treated area for three weeks.
Where can clinics buy Neauvia Intense Rose?
ALLPARA supplies Neauvia Intense Rose to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.